Mersana Therapeutics MRSN
$ 2.05
3.54%
Quarterly report 2024-Q3
added 11-13-2024
Mersana Therapeutics EV/EBITDA Ratio 2011-2024 | MRSN
Annual EV/EBITDA Ratio Mersana Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
221 | -12.1 | -8.5 | -0.712 | -3.98 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
221 | -12.1 | 39.1 |